School of Rehabilitation Science, McMaster University, Hamilton, Ontario, Canada.
Department of Respiratory Medicine, Toronto, Ontario, Canada.
COPD. 2021 Apr;18(2):254-263. doi: 10.1080/15412555.2021.1897559. Epub 2021 Mar 12.
This systematic review aimed to synthesize the evidence of the psychometric properties of self-efficacy patient-reported outcome measures (PROMs) in patients with chronic obstructive pulmonary disease (COPD). We conducted a systematic search of MEDLINE and other common databases from inception until September 2020. Studies that reported psychometric properties of self-efficacy outcome measures in COPD patients were included. We used the Consensus-Based Standards for the Selection of Health Measurement Instruments (COSMIN) 2018 guidelines for data extraction and evidence synthesis. Eighteen studies that assessed nine self-efficacy PROMs were eligible for inclusion. The assessment of structural validity indicated sufficient results rating for the Exercise Self-Regulatory Efficacy Scale and the Self-Care-Self-Efficacy Scale, and insufficient rating for the COPD Self-Efficacy Scale and the Pulmonary Rehabilitation Adaptation Index for Self-Efficacy (PRAISE). Construct validity measures displayed sufficient results rating with correlations ranging from -0.48 to - 0.71 between self-efficacy PROMs and other PROMs such as St. George's Respiratory Questionnaire, Hospital Anxiety and Depression Scale and Chronic Respiratory Questionnaire. Internal consistency measures indicated sufficient rating for all self-efficacy PROMs with a Cronbach's alpha range of 0.71 - 0.98. Responsiveness was assessed for the PRAISE with an overall sufficient rating (effect sizes of 0.21 - 0.37). The evidence regarding the psychometric properties of self-efficacy PROMs in COPD is variable. The PRAISE is responsive to changes in self-efficacy in COPD patients attending a pulmonary rehabilitation program. When using self-efficacy PROMs in clinical practice or research, clinicians and researchers should consider the psychometric properties and choose the appropriate outcome measure based on the purpose.
本系统评价旨在综合慢性阻塞性肺疾病(COPD)患者自我效能患者报告结局测量(PROM)的心理测量特性证据。我们对 MEDLINE 和其他常见数据库进行了系统搜索,从开始到 2020 年 9 月。纳入了报告 COPD 患者自我效能结局测量心理测量特性的研究。我们使用基于共识的健康测量仪器选择标准(COSMIN)2018 指南进行数据提取和证据综合。有 18 项研究评估了 9 种自我效能 PROM,符合纳入标准。结构有效性评估表明,Exercise Self-Regulatory Efficacy Scale 和 Self-Care-Self-Efficacy Scale 的结果评级为足够,COPD Self-Efficacy Scale 和 Pulmonary Rehabilitation Adaptation Index for Self-Efficacy(PRAISE)的结果评级为不足。构念有效性测量结果评级为足够,自我效能 PROM 与其他 PROM(如 St. George's Respiratory Questionnaire、Hospital Anxiety and Depression Scale 和 Chronic Respiratory Questionnaire)之间的相关性为 -0.48 至 -0.71。内部一致性测量结果显示,所有自我效能 PROM 的评级均为足够,Cronbach's alpha 范围为 0.71-0.98。对 PRAISE 的反应性进行了评估,总体评级为足够(效应大小为 0.21-0.37)。COPD 患者自我效能 PROM 的心理测量特性证据存在差异。PRAISE 对参加肺康复计划的 COPD 患者自我效能的变化具有反应性。当在临床实践或研究中使用自我效能 PROM 时,临床医生和研究人员应考虑心理测量特性,并根据目的选择适当的结局测量工具。